# Antenatal Allopurinol During Fetal Hypoxia

> **NCT00189007** · PHASE3 · UNKNOWN · sponsor: **UMC Utrecht** · enrollment: 222 (actual)

## Conditions studied

- Fetal Hypoxia
- Reperfusion Injury

## Interventions

- **DRUG:** Allopurinol sodium
- **DRUG:** Mannitol

## Key facts

- **NCT ID:** NCT00189007
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2011-12
- **Final completion:** 2016-12
- **Target enrollment:** 222 (ACTUAL)
- **Last updated:** 2012-03-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189007, "Antenatal Allopurinol During Fetal Hypoxia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00189007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*